GlassScriptPhysician profile
Amber L Simmons
NPI 1922477884
$3,850.37
in general payments reported to CMS, 2019-2025
29 companies · $1,072 in 2025
The $1,072 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.60 · 2022: $594 · 2023: $937 · 2024: $1,193 · 2025: $1,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,201.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $832.61 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $664.64 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $554.28 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $413.66 | 2022-2025 | Repatha, Evenity, Prolia |
| Merck Sharp & Dohme LLC | $266.28 | 2022-2025 | Verquvo, Belsomra, Steglatro |
| Phathom Pharmaceuticals, INC. | $132.96 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $131.83 | 2023-2025 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $95.90 | 2022-2025 | |
| Abbott Laboratories | $92.96 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $90.84 | 2022-2023 | |
| Astellas Pharma US INC | $80.97 | 2024-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $61.19 | 2023-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $48.08 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $44.05 | 2022 | |
| Corium, LLC | $43.70 | 2023-2024 | Azstarys |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $40.81 | 2025 | Inspire |
| Exact Sciences Corporation | $40.08 | 2024 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $37.43 | 2025 | |
| Janssen Pharmaceuticals, INC | $30.59 | 2023-2024 | Xarelto |
| Tandem Diabetes Care, INC. | $21.09 | 2022 | |
| Eisai INC. | $16.04 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.00 | 2024 | Livalo |
| Irhythm Technologies, INC. | $14.18 | 2023 | Zio Xt Patch |
| Seqirus USA INC | $14.16 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Collegium Pharmaceutical, INC. | $14.10 | 2025 | Jornay Pm |
| Sumitomo Pharma America, INC. | $13.84 | 2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.60 | 2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.34 | 2022 | |
| Emmaus Medical, INC. | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.